CELLECTIS has choosen ACCELERA as the preferred partner to provide the preclinical studies for UCART19
Download  full  announcement

To know more about the agreement
Karolinska Development / Accelera

Click Here

Do you have a Drug Candidate
to move to Clinics?

Accelera helps you
contact  us


Partnering Conference
(1:1 Meetings)

Frankfurt, November 2-5, 2014

Click here to know more


Partnering Conference
(1:1 Meetings)

Santiago de Compostela, September 24-26, 2014

Click here to know more

Accelera Bioanalysis
experts at
EBF 2014

(Poster at Booth B34)

Barcelona, November 19-21